Laminar Pharma
About:
Laminar Pharma is a biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
Website: https://laminarpharma.com/
Top Investors: Capital Cell, OK Venture, Dentol Capital
Description:
LAMINAR PHARMA is a pioneering biopharmaceutical company that focuses on the discovery, rational design and initial clinical development of a new generation of medicines associated with a novel therapeutic approach: Membrane Lipid Therapy (MLT).
Total Funding Amount:
10.8M EUR
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Palma De Mallorca, Islas Baleares, Spain
Founded Date:
2006-01-01
Contact Email:
info(AT)laminarpharma.com
Founders:
PABLO V. ESCRIBA
Number of Employees:
11-50
Last Funding Date:
2023-10-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai